ALLIAR (AALR3) Main Indicators
Basic Data - AALR3
| Company | ALLIAR |
| Corporate Name | ALLIANÇA SAÚDE E PARTICIPAÇÕES S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Prestação de serviços de medicina diagnóstica |
| Share | AALR3 |
| Quote Date | 04/01/2025 |
| Share Type | ON |
| Last Closing | R$ 6.85 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 1.45 M |
| Last Statement | DFP - 12/31/2024 |
| Sector | Saúde |
| Subsector | Serv.Méd.Hospit..Análises e Diagnósticos |
| Segment | Serv.Méd.Hospit..Análises e Diagnósticos |
| Participation Indexes | IGC, IGNM, ITAG |
| Updated 04/02/2025 | |
Relative Prices - AALR3
| Price/Earnings | -8.48 |
| Price/SBV | 0.95 |
| Price/Net Sales | 0.86 |
| Price/CFO | -25.44 |
| Price/FCF | -7.43 |
| Price/Total Assets | 0.36 |
| Price/EBIT | 9.24 |
| Price/Working Capital | 37.23 |
| Price/NCAV | -0.59 |
| EV/EBIT | 14.60 |
| EV/EBITDA | 7.47 |
| EV/Net Sales | 1.36 |
| EV/CFO | -40.23 |
| EV/FCF | -11.75 |
| EV/Total Assets | 0.57 |
| Company Market Cap | R$ 1.04 B |
| Enterprise Value | R$ 1.65 B |
| Current Financial Statement Date | 12/31/2024 |
| Current Share Price | R$ 6.85 |
| Share Price Date | 04/01/2025 |
| Dividend Yield | 0.00% |
| Updated 04/02/2025 | |
Income Statement - AALR3
| Net Revenue | R$ 1.22 B |
| Gross Result | R$ 355.66 M |
| EBIT | R$ 113.01 M |
| Depreciation and Amortization | - R$ 107.84 M |
| EBITDA | R$ 220.85 M |
| Net Profit | - R$ 123.09 M |
| Net Profit/Share | - R$ 1.04 |
| Updated 03/25/2025 | |
| Net Revenue | R$ 300.67 M |
| Gross Result | R$ 77.45 M |
| EBIT | R$ 20.49 M |
| Depreciation and Amortization | - R$ 27.12 M |
| EBITDA | R$ 47.62 M |
| Net Profit | - R$ 46.58 M |
| Profit/Share | - R$ 0.39 |
| Updated 03/25/2025 | |
Price and Volume Behavior - AALR3
| Lowest Price 52 weeks | R$ 6.85 |
| Highest Price 52 weeks | R$ 17.07 |
| Variation 2025 | -14.38% |
| Variation 1 year | -25.54% |
| Variation 2 years(total) | -69.60% |
| Variation 2 years(yearly) | -44.77% |
| Variation 3 years(total) | -62.85% |
| Variation 3 years(yearly) | -28.09% |
| Variation 4 years(total) | -22.60% |
| Variation 4 years(yearly) | -6.20% |
| Variation 5 years(total) | -17.38% |
| Variation 5 years(yearly) | -3.75% |
| Average Daily Volume (3 months) | R$ 2.12 M |
| Updated 04/02/2025 | |
Returns and Margins - AALR3
| Return on Initial Tangible Capital | 6.84% |
| Return on Initial Invested Capital | 4.28% |
| Pre-Tax Return on Initial Tangible Capital | 10.36% |
| Pre-Tax Return on Initial Invested Capital | 6.48% |
| Return on Initial Shareholder´s Equity | -13.42% |
| Return on Initial Asset | -4.61% |
| Gross Margin | 29.22% |
| Net Margin | -10.11% |
| EBIT Margin | 9.29% |
| EBITDA Margin | 18.15% |
| Initial Asset Turnover | 0.46 |
| Financial Leverage | 2.64 |
| Liabilities/Net Worth | 1.64 |
| Net Debt/EBITDA | 2.75 |
| Updated 03/25/2025 | |
Balance Sheet - AALR3
| Cash and Cash Equivalents | R$ 114.97 M |
| Total Assets | R$ 2.89 B |
| Short-Term Debt | R$ 293.99 M |
| Long-Term Debt | R$ 427.72 M |
| Gross Debt | R$ 721.71 M |
| Net Debt | R$ 606.74 M |
| Shareholder´s Equity | R$ 1.09 B |
| Share Book Value | R$ 9.25 |
| Common Shares | 118,292,816 |
| Preferred Shares | 0 |
| Total | 118,292,816 |
| Common Shares in Treasury | 90,827 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 90,827 |
| Common Shares (Except Treasury) | 118,201,989 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 118,201,989 |
| Updated 03/25/2025 | |
Cash Flow - AALR3
| Operating Cash Flow | - R$ 41.02 M |
| Cash Flow from Investments | R$ 142.41 M |
| Financing Cash Flow | - R$ 205.01 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 103.62 M |
| Updated 03/25/2025 | |
| Operating Cash Flow | - R$ 236.61 M |
| Cash Flow from Investments | R$ 239.41 M |
| Financing Cash Flow | - R$ 55.53 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 52.73 M |
| Updated 03/25/2025 | |
Experimental - AALR3
| CAPEX 3 months | - R$ 20.32 M |
| Free Cash Flow 3 months | - R$ 256.93 M |
| CAPEX 12 months | - R$ 99.39 M |
| Free Cash Flow 12 months | - R$ 140.41 M |
| Updated 03/25/2025 | |